Secretory phospholipase A2-IIa, a potential biomarker for prostate cancer, is regulated by the HER/HER2-elicited pathway

被引：0
|
作者：
Oleksowicz, Leslie
Liu, Yin [1 ]
Bracken, R. Bruce
Gaitonde, Krishnanath
Burke, Barbara
Succop, Paul
Levin, Linda
Dong, Zhongyun
Lu, Shan [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH 45237 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2011年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
296
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Proapoptotic activity of secretory group IIA phospholipase A2 is regulated by nuclear factor κB
    Liang, S
    Herman, B
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 162A - 162A
  • [32] Limits of Mendelian Randomization Analyses in Selection of Secretory Phospholipase A2-IIA as a Valid Therapeutic Target for Prevention of Cardiovascular Disease Reply
    Holmes, Michael V.
    Simon, Tabassome
    Exeter, Holly J.
    Hingorani, Aroon D.
    Sabatine, Marc S.
    Mallat, Ziad
    Casas, Juan P.
    Talmud, Philippa J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (09) : 943 - 943
  • [33] Serum HER2 as potential prognostic biomarker in primary breast cancer patients
    Todorovic-Rakovic, Natasa
    Milovanovic, Jelena
    Radulovic, Marko
    Greenman, John
    GROWTH FACTORS, 2025,
  • [34] Characterization of meFucoidan as a selective inhibitor for secretory phospholipase A2-IIA and the phosphorylation of meFucoidan-binding proteins by A-kinase in vitro
    Maruyama, Hiroko
    Suzuki, Kanzo
    Miyai, Sayaka
    Ohtsuki, Kenzo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (04) : 714 - 718
  • [35] The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond
    Jacot, William
    Fiche, Maryse
    Zaman, Khalil
    Wolfer, Anita
    Lamy, Pierre-Jean
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (01): : 146 - 157
  • [36] Secretory phospholipase (sPLA2-IIA) regulates breast cancer stem cells differentiation and metastatic potential
    Mehta, Darshan
    Shaikh, Sana
    Mohanty, Bhabani
    Chaudhari, Pradip
    Waghmare, Sanjeev K.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 677 : 98 - 104
  • [37] HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
    Freeman, MR
    CANCER CELL, 2004, 6 (05) : 427 - 428
  • [38] Measurement of a Novel Biomarker, Secretory Phospholipase A2 Group IIA as a Marker of Sepsis: A Pilot Study
    Berg, Elena
    Paukovits, Janel
    Axelband, Jennifer
    Trager, Jonathan
    Ryan, Dina
    Cichonski, Kathleen
    Kopnitsky, Mark
    Zweitzig, Daniel
    Jeanmonod, Rebecca
    JOURNAL OF EMERGENCIES TRAUMA AND SHOCK, 2018, 11 (02) : 135 - 139
  • [39] HER-2/neu expression in metastatic prostate cancer:: Potential target for immunotherapy
    Li, M
    True, LD
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 549 - 549
  • [40] HER2-low and gastric cancer: A prognostic biomarker?
    de Mendonca Uchoa, Bruno Cezar
    Pirolli, Rafaela
    Mendes Gomes Siqueira, Luciana Beatriz
    Rocha Moura, Francisca Giselle
    Rondina Correa, Ana Paula
    Batista Rosado, Jose Ecio
    Chinelato, Juliana Rosa
    Felismino, Tiago
    Fonseca Jesus, Victor Hugo
    Spina Donadio, Mauro Daniel
    Melo, Everton
    Cesca, Marcelle Goldner
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345